Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611

Roy Eldor; Noa Avraham; Orit Rosenberg; Miriam Shpigelman; Avivit Golan-Cohen; Tali Cukierman-Yaffe; Eugene Merzon; Assaf Buch

doi:10.2337/dc26-er02a

Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611

Roy Eldor
, Noa Avraham
, Orit Rosenberg
, Miriam Shpigelman
, Avivit Golan-Cohen
, Tali Cukierman-Yaffe
, Eugene Merzon
, Assaf Buch

Department of Nutrition Sciences

Research output: Contribution to journal › Comment/debate

Abstract

In the article cited above, the affiliations for author Assaf Buch were incorrectly given as Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, and Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The sole affiliation for this author is Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The online version of the article (https://doi.org/10.2337/dc25-0690) has been updated with the correct affiliation information.

Original language	English
Pages (from-to)	361
Number of pages	1
Journal	Diabetes Care
Volume	49
Issue number	2
DOIs	https://doi.org/10.2337/dc26-er02a https://doi.org/10.2337/dc26-er02a
State	Published - 1 Feb 2026

Access to Document

Fingerprint

Dive into the research topics of 'Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611'. Together they form a unique fingerprint.

Cite this

Eldor, R., Avraham, N., Rosenberg, O., Shpigelman, M., Golan-Cohen, A., Cukierman-Yaffe, T., Merzon, E., & Buch, A. (2026). Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611. Diabetes Care, 49(2), 361. https://doi.org/10.2337/dc26-er02a, https://doi.org/10.2337/dc26-er02a

Eldor, Roy ; Avraham, Noa ; Rosenberg, Orit et al. / Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events : A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611. In: Diabetes Care. 2026 ; Vol. 49, No. 2. pp. 361.

@article{5c7d475c9047402c87c92363853409db,

title = "Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611",

abstract = "In the article cited above, the affiliations for author Assaf Buch were incorrectly given as Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, and Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The sole affiliation for this author is Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The online version of the article (https://doi.org/10.2337/dc25-0690) has been updated with the correct affiliation information.",

author = "Roy Eldor and Noa Avraham and Orit Rosenberg and Miriam Shpigelman and Avivit Golan-Cohen and Tali Cukierman-Yaffe and Eugene Merzon and Assaf Buch",

year = "2026",

month = feb,

day = "1",

doi = "10.2337/dc26-er02a",

language = "אנגלית",

volume = "49",

pages = "361",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association Inc.",

number = "2",

}

Eldor, R, Avraham, N, Rosenberg, O, Shpigelman, M, Golan-Cohen, A, Cukierman-Yaffe, T, Merzon, E & Buch, A 2026, 'Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611', Diabetes Care, vol. 49, no. 2, pp. 361. https://doi.org/10.2337/dc26-er02a, https://doi.org/10.2337/dc26-er02a

Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611. / Eldor, Roy; Avraham, Noa; Rosenberg, Orit et al.
In: Diabetes Care, Vol. 49, No. 2, 01.02.2026, p. 361.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events

T2 - A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611

AU - Eldor, Roy

AU - Avraham, Noa

AU - Rosenberg, Orit

AU - Shpigelman, Miriam

AU - Golan-Cohen, Avivit

AU - Cukierman-Yaffe, Tali

AU - Merzon, Eugene

AU - Buch, Assaf

PY - 2026/2/1

Y1 - 2026/2/1

N2 - In the article cited above, the affiliations for author Assaf Buch were incorrectly given as Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, and Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The sole affiliation for this author is Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The online version of the article (https://doi.org/10.2337/dc25-0690) has been updated with the correct affiliation information.

AB - In the article cited above, the affiliations for author Assaf Buch were incorrectly given as Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, and Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The sole affiliation for this author is Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The online version of the article (https://doi.org/10.2337/dc25-0690) has been updated with the correct affiliation information.

UR - https://www.scopus.com/pages/publications/105028171563

U2 - 10.2337/dc26-er02a

DO - 10.2337/dc26-er02a

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 41337783

SN - 1935-5548

VL - 49

SP - 361

JO - Diabetes Care

JF - Diabetes Care

IS - 2

ER -

Eldor R, Avraham N, Rosenberg O, Shpigelman M, Golan-Cohen A, Cukierman-Yaffe T et al. Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611. Diabetes Care. 2026 Feb 1;49(2):361. doi: 10.2337/dc26-er02a, 10.2337/dc26-er02a

Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611

Abstract

Access to Document

Other files and links

Fingerprint

Cite this